These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
362 related articles for article (PubMed ID: 20096354)
1. Using transdermal iontophoresis to increase granisetron delivery across skin in vitro and in vivo: effect of experimental conditions and a comparison with other enhancement strategies. Cázares-Delgadillo J; Ganem-Rondero A; Quintanar-Guerrero D; López-Castellano AC; Merino V; Kalia YN Eur J Pharm Sci; 2010 Mar; 39(5):387-93. PubMed ID: 20096354 [TBL] [Abstract][Full Text] [Related]
3. Controlled transdermal iontophoresis for poly-pharmacotherapy: Simultaneous delivery of granisetron, metoclopramide and dexamethasone sodium phosphate in vitro and in vivo. Cázares-Delgadillo J; Ganem-Rondero A; Merino V; Kalia YN Eur J Pharm Sci; 2016 Mar; 85():31-8. PubMed ID: 26826281 [TBL] [Abstract][Full Text] [Related]
4. Controlled iontophoretic delivery of pramipexole: electrotransport kinetics in vitro and in vivo. Kalaria DR; Patel P; Merino V; Patravale VB; Kalia YN Eur J Pharm Biopharm; 2014 Sep; 88(1):56-63. PubMed ID: 24525072 [TBL] [Abstract][Full Text] [Related]
5. Non-invasive iontophoretic delivery of enzymatically active ribonuclease A (13.6 kDa) across intact porcine and human skins. Dubey S; Kalia YN J Control Release; 2010 Aug; 145(3):203-9. PubMed ID: 20423719 [TBL] [Abstract][Full Text] [Related]
6. Transdermal iontophoresis of dexamethasone sodium phosphate in vitro and in vivo: effect of experimental parameters and skin type on drug stability and transport kinetics. Cázares-Delgadillo J; Balaguer-Fernández C; Calatayud-Pascual A; Ganem-Rondero A; Quintanar-Guerrero D; López-Castellano AC; Merino V; Kalia YN Eur J Pharm Biopharm; 2010 Jun; 75(2):173-8. PubMed ID: 20332024 [TBL] [Abstract][Full Text] [Related]
7. Controlled iontophoretic transport of huperzine A across skin in vitro and in vivo: effect of delivery conditions and comparison of pharmacokinetic models. Kalaria DR; Patel P; Merino V; Patravale VB; Kalia YN Mol Pharm; 2013 Nov; 10(11):4322-9. PubMed ID: 24028565 [TBL] [Abstract][Full Text] [Related]
8. Controlled non-invasive transdermal iontophoretic delivery of zolmitriptan hydrochloride in vitro and in vivo. Patel SR; Zhong H; Sharma A; Kalia YN Eur J Pharm Biopharm; 2009 Jun; 72(2):304-9. PubMed ID: 18771728 [TBL] [Abstract][Full Text] [Related]
9. In vitro transdermal iontophoretic delivery of penbutolol sulfate. Ita KB; Banga AK Drug Deliv; 2009 Jan; 16(1):11-4. PubMed ID: 19555303 [TBL] [Abstract][Full Text] [Related]
11. Microneedle assisted iontophoretic transdermal delivery of prochlorperazine edisylate. Kolli CS; Xiao J; Parsons DL; Babu RJ Drug Dev Ind Pharm; 2012 May; 38(5):571-6. PubMed ID: 21980925 [TBL] [Abstract][Full Text] [Related]
12. Iontophoretic transport kinetics of ketorolac in vitro and in vivo: demonstrating local enhanced topical drug delivery to muscle. Gratieri T; Pujol-Bello E; Gelfuso GM; de Souza JG; Lopez RF; Kalia YN Eur J Pharm Biopharm; 2014 Feb; 86(2):219-26. PubMed ID: 23791718 [TBL] [Abstract][Full Text] [Related]
13. Comparison of the cutaneous iontophoretic delivery of rasagiline and selegiline across porcine and human skin in vitro. Kalaria DR; Patel P; Patravale V; Kalia YN Int J Pharm; 2012 Nov; 438(1-2):202-8. PubMed ID: 22954444 [TBL] [Abstract][Full Text] [Related]
14. Transdermal iontophoresis of hydromorphone across hairless rat skin in vitro. Kumar MG; Lin S Pharm Dev Technol; 2009; 14(1):106-15. PubMed ID: 18825546 [TBL] [Abstract][Full Text] [Related]
15. Noninvasive transdermal iontophoretic delivery of biologically active human basic fibroblast growth factor. Dubey S; Perozzo R; Scapozza L; Kalia YN Mol Pharm; 2011 Aug; 8(4):1322-31. PubMed ID: 21696184 [TBL] [Abstract][Full Text] [Related]
16. Effect of amino acid sequence on transdermal iontophoretic peptide delivery. Schuetz YB; Naik A; Guy RH; Kalia YN Eur J Pharm Sci; 2005 Dec; 26(5):429-37. PubMed ID: 16143501 [TBL] [Abstract][Full Text] [Related]
17. In-vitro and in-vivo transdermal iontophoretic delivery of tramadol, a centrally acting analgesic. Takasuga S; Yamamoto R; Mafune S; Sutoh C; Kominami K; Yoshida Y; Ito M; Kinoshita M J Pharm Pharmacol; 2011 Nov; 63(11):1437-45. PubMed ID: 21988424 [TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo transdermal iontophoretic delivery of naloxone, an opioid antagonist. Yamamoto R; Takasuga S; Yoshida Y; Mafune S; Kominami K; Sutoh C; Kato Y; Yamauchi M; Ito M; Kanamura K; Kinoshita M Int J Pharm; 2012 Jan; 422(1-2):132-8. PubMed ID: 22108639 [TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo evaluation of the transdermal iontophoretic delivery of sumatriptan succinate. Patel SR; Zhong H; Sharma A; Kalia YN Eur J Pharm Biopharm; 2007 May; 66(2):296-301. PubMed ID: 17182233 [TBL] [Abstract][Full Text] [Related]